Zeph

Market position

Zeph operates in virtual pulmonary rehabilitation and remote respiratory monitoring, a segment that also includes BreatheSuite, Conversio Health and FlexTogether according to a respiratory healthtech startup directory. The company frames its opportunity around large untreated demand, citing 24 million Americans living with COPD, 96% of COPD patients not receiving pulmonary rehabilitation, only 3% of eligible COPD patients completing traditional programs, and $50 billion in annual U.S. COPD costs.

The offering combines synchronous therapist-guided group rehabilitation delivered by video with asynchronous maintenance programming, real-time streamed pulse oximetry and heart rate for in-session safety supervision, supplied patient hardware, gamified exercises, billing support through pulmonary rehabilitation codes, and optional EHR integration — aimed at raising completion rates relative to facility-based rehabilitation.

Technology

A web app for clinicians and a pre-configured patient tablet run a telemedicine environment designed for group pulmonary rehabilitation visits, combined with AI-assisted personalization of care. Vitals are streamed in real time from FDA-approved Bluetooth-connected pulse oximetry and heart rate devices so clinicians can view live video and patient data simultaneously during sessions. The separate Zeph Trainer device uses clinical-grade respiratory sensors to measure lung function and breathing patterns, syncing wirelessly to iOS and Android apps that generate a breathability score and guided exercises. The platform can integrate with provider EHRs over roughly four weeks, ranging from PDF reports to structured assessment results and session progress; beyond the initial referral, Zeph states it does not pull data from the EHR.

Go-to-market

Zeph sells to clinical practices and healthcare organizations, positioning deployment as a three-step fit into existing workflows requiring only an internet-connected computer for the provider. Marketing emphasizes clinician testimonials, published evidence on pulmonary rehabilitation outcomes, billing enablement and low patient setup burden through shipped, preloaded tablets and 1:1 onboarding. A third-party respiratory healthtech startup directory also lists the company.

Healthcare providers, clinicians and care teams treating chronic respiratory disease, and their patients — including people with COPD from mild to severe, interstitial lung disease, pulmonary hypertension, bronchiectasis (cystic fibrosis and non-CF), severe asthma, post-COVID breathing problems, patients recovering from ICU stays or major respiratory events, lung volume reduction patients, lung cancer patients and lung transplant candidates and recipients.

Geography

United States.

History

Zeph Technologies was established in 2023 and is focused on AI-enabled pulmonary care, with a remote pulmonary rehabilitation platform for patients with chronic respiratory conditions, particularly COPD, as its primary product.

Risks & controversies

The program depends on patient internet connectivity and comfort with tablets among an older chronic-disease population, on provider reimbursement through pulmonary rehabilitation billing codes, and on IT-dependent EHR integration work at each customer site.